OptimizeRx (OPRX) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50% |
| Dec 31, 2025 | 0.57% |
| Sep 30, 2025 | -1.92% |
| Jun 30, 2025 | -5.38% |
| Mar 31, 2025 | -3.91% |
| Dec 31, 2024 | -3.79% |
| Sep 30, 2024 | -3.36% |
| Jun 30, 2024 | -0.99% |
| Mar 31, 2024 | 0.19% |
| Dec 31, 2023 | 36.30% |
| Sep 30, 2023 | 35.49% |
| Jun 30, 2023 | 38.60% |
| Mar 31, 2023 | 41.64% |
| Dec 31, 2022 | 41.13% |
| Sep 30, 2022 | 46.59% |
| Jun 30, 2022 | 49.78% |
| Mar 31, 2022 | 88.90% |
| Dec 31, 2021 | 92.36% |
| Sep 30, 2021 | 94.62% |
| Jun 30, 2021 | 99.09% |
| Mar 31, 2021 | 161.24% |
| Dec 31, 2020 | 100.28% |
| Sep 30, 2020 | 97.58% |
| Jun 30, 2020 | 88.74% |
| Mar 31, 2020 | 83.51% |
| Dec 31, 2019 | 79.08% |
| Sep 30, 2019 | 72.31% |
| Jun 30, 2019 | 72.57% |
| Mar 31, 2019 | 31.52% |
| Dec 31, 2018 | 27.32% |
| Sep 30, 2018 | 23.03% |
| Jun 30, 2018 | 49.77% |
| Mar 31, 2018 | 14.28% |
| Dec 31, 2017 | 10.50% |
| Sep 30, 2017 | 7.64% |
| Jun 30, 2017 | 10.59% |
| Mar 31, 2017 | 15.32% |
| Dec 31, 2016 | 67.30% |
| Sep 30, 2016 | 57.29% |
| Jun 30, 2016 | 65.97% |
| Mar 31, 2016 | 83.17% |
| Dec 31, 2015 | 85.33% |
| Sep 30, 2015 | 90.61% |
| Jun 30, 2015 | 50.10% |
| Mar 31, 2015 | 48.13% |
| Dec 31, 2014 | 42.62% |
| Sep 30, 2014 | 36.45% |
| Jun 30, 2014 | 54.40% |
| Dec 31, 2013 | -4.14% |